Search

His aim is to develop a vaccine against the widespread gastric pathogen Helicobacter pylori: for his work in this field, Professor Markus Gerhard, Technische Universität München (TUM), was awarded the

Infectious diseases are a leading cause of death worldwide. Current problems such as antibiotic resistance, declining vaccination rates and emerging infections like Ebola present scientists and

Researchers of the Paul Ehrlich Institute (PEI) together with groups at the DZIF have developed a vaccine against MERS, that is highly immunogenic and indicates protection of vaccinated mice in

There is a ray of hope in the fight against the dangerous MERS coronavirus (MERS-CoV): a single vaccine could potentially be sufficient to effectively fight all known MERS-CoV genetic lineages

In the EU project “EVIDENT”, scientists investigated around 180 patient samples from the Ebola epidemic in West Africa, to elucidate the origin of the epidemic in the individual countries and the

DZIF researchers at the LMU Munich have successfully tested their candidate vaccine against MERS coronavirus in a preclinical trial. Plans for a clinical trial, in which the virus will be tested in

In the DZIF, scientists from the universities of Tübingen, Münster and Munich join forces and prepare together with the company Hyglos clinical studies on an active substance against the dreaded

30 years after HIV was discovered to be the cause of the acquired immune deficiency syndrome AIDS, and despite intensive research, no vaccine or cure has yet been found. An international team of

The initial results of a clinical Phase I trial of a potential vaccine against the dreaded Ebola virus are now available. At the Hamburg-Eppendorf University Medical Center (UKE), in Geneva